Product Pipeline
Product Overview
Our strategy is to search for opportunities where we can use our protein purification, molecular biology abilities and utilization of genomics and proteomics to create unique and if possible, proprietary patented products. We focus on expanding into other uses for purified proteins, principally for diagnosis and treatment of animals and humans. An important factor in diagnostics products is the vastly reduced times required from product conception to saleable product as compared to therapeutic products which often require many years to market, due to significantly more stringent FDA requirements for therapeutic products.
Products we have in our pipeline consist of product candidates in various stages of clinical and pre-clinical development. One of our business strategies is to focus primarily on products and technologies which we believe have an attractive time line to revenue. We pursue technologies under "in-licensing" agreements with universities, researchers or doctors; complete research and development on the technologies through proof of concept, and then either "out-license" to "Big Pharma" companies and/or go to product introduction and launch.
Following is a summary of our current key products and their development status:
| Product | Use | Stage | Revenue | FDA Approval |
| SurBred™ | Pregnancy status | Development | Pre | N/A |
| Licensed Recombinant Analogs: | ||||
| BoviPure LH™ | Pregnancy maintenance | Development | Pre | Pre |
| BoviPure FSH™ | Super bovine ovulation | Development | Pre | Pre |
| EquiPure LH™ | Induce equine ovulation | Development | Initial | Applied |
| EquiPure FSH™ | Super equine ovulation | Development | Pre | Pre |
| Appendicitis Test | Rule out condition | Development | Pre | Pre |
